Johnson & Johnson (JNJ) Stock Is Skyrocketing Over 15% This Year: Will It Continue to Surge?

Johnson & Johnson (JNJ) are recovering from a big dip that they faced in June. Now the stock price is equal to $169 and the monthly report shows an increase of +5%. The total revenue of the company is $82.584 billion. Heading into today, shares of the world’s biggest maker of health care products had gained 2.49% over the past month, outpacing the Medical sector’s loss of 3.66%. Johnson & Johnson (JNJ) is an Us-based global firm that develops health devices, pharmaceutical supplies, and customer packaged goods. Johnson & Johnson (JNJ) is ranked No. 36 on the 2021 Fortune 500 list of the largest United States companies by total revenue. Johnson & Johnson is one of the world’s most worthwhile companies and is one of only two U.S.-based companies.

Nowadays, JNJ will be looking to display power as it nears its next income discharge, which is expected to be July 21, 2021. In that report, analysts expect JNJ to post earnings of $2.28 per share. This would mark year-over-year growth of 36.53%.

Paul Meyer

Part-Time Reporter. Paul could do better in his engineering profession where he became a real pro. However, he chose the finance field to find a tranquil environment in his career. Today he creates a good number of great content for our team.

Want Hot Stocks?    Yes. I Love Them No thanks